28 – 29 October 2021 | London, UK
+ Digital Day: 01 November 2021 | Online

Chris Bond

Vice President, Cell ular Engineering
Kite, A Gilead Company
Chris Bond
Chris Bond, PhD is Vice President of Cellular Engineering at Kite Pharma. Dr. Bond was previously the Senior Director of Lead Discovery at Juno Therapeutics and the Head of Biologics for Canada’s Centre for Drug Research and Development.

Sessions

No data was found